Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > ASH 2024: Roundup of news from last day of hematology meeting
Health and Wellness

ASH 2024: Roundup of news from last day of hematology meeting

Last updated: December 10, 2024 7:35 pm
Share
ASH 2024: Roundup of news from last day of hematology meeting
SHARE

The ASH 2024 conference has been buzzing with exciting developments in the field of hematology. As the conference comes to a close in San Diego, attendees are already looking forward to next year’s event in Orlando. Here is a recap of some of the most notable news from the conference:

The feud between Arcellx and Legend Biotech over their anti-BCMA CAR-T therapies for multiple myeloma has been making headlines. Arcellx received a special waiver to issue an early press release highlighting the lack of delayed neurotoxicity associated with its experimental treatment, anito-cel, in an attempt to disrupt Legend’s investor meeting. Legend, on the other hand, remains confident in its own therapy, Carvykti, which has already established itself as a standard-of-care treatment for multiple myeloma.

In a significant development for mantle cell lymphoma patients, a randomized trial has shown that autologous stem cell transplants may not be necessary for patients in deep remission after initial therapy. The results of the trial have reinforced the growing trend among clinicians to move away from transplants for these patients, as newer targeted and immune therapies have improved outcomes significantly.

Amgen’s Blincyto has shown promising results in improving disease-free survival in pediatric patients with acute lymphoblastic leukemia. The bispecific T-cell engager, when added to standard chemotherapy, significantly increased three-year disease-free survival rates in children with B-cell ALL. While the treatment may come with some risks, particularly infections, it has shown to be beneficial for high-risk populations.

For patients with chronic lymphocytic leukemia who have failed other treatments, Abbvie’s Epkinly, a bispecific T-cell engager, may offer a chance for complete remission. In a phase 1/2 trial, a significant number of patients responded to the drug, with some achieving a complete response. This is a promising development for CLL patients who have limited treatment options after relapse.

See also  How Wildfires Can Affect Human Health

Overall, the ASH 2024 conference has showcased the latest advancements in hematology research and treatment options. From cutting-edge CAR-T therapies to promising new drug combinations, the future looks bright for patients with hematologic disorders. Stay tuned for more updates and breakthroughs in hematology as we look forward to next year’s conference in Orlando.

TAGGED:AshDayhematologyMeetingNewsRoundup
Share This Article
Twitter Email Copy Link Print
Previous Article Most picked teams in Honkai Star Rail 2.6 Memory of Chaos Most picked teams in Honkai Star Rail 2.6 Memory of Chaos
Next Article Chronic Spontaneous Urticaria: One Women’s Diagnosis Journey Chronic Spontaneous Urticaria: One Women’s Diagnosis Journey
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Lifeguards Not on Duty at Beach Where Malcolm-Jamal Warner’s Drowned

The tragic death of Malcolm-Jamal Warner at Playa Grande has sparked controversy surrounding the lack…

July 22, 2025

Wang Mansheng Turns to Nature to Make His Own Paintbrushes from Organic Materials — Colossal

Wang Mansheng, a Chinese painter and calligrapher, challenges the notion that expensive, factory-made art supplies…

July 17, 2025

Xingzi Gu Shows the Vulnerability of Youth

Xingzi Gu’s ethereal paintings of young adults on the verge of adulthood have captivated art…

May 25, 2025

What do climate protests actually achieve? More than you think.

The recent "Hands Off!" protests against President Donald Trump's return to the White House drew…

April 11, 2025

CBS News Journo Predicts Trump Will Get to Appoint a Fourth Justice to the U.S. Supreme Court This Coming Year or Next (VIDEO) |

Jan Crawford, a CBS News journalist, made a bold prediction over the weekend that President…

December 30, 2024

You Might Also Like

Nearly 1 in 5 urinary tract infections linked to contaminated meat
Health and Wellness

Nearly 1 in 5 urinary tract infections linked to contaminated meat

October 31, 2025
Cigna Profits Hit Nearly  Billion Despite Rising Costs
Health and Wellness

Cigna Profits Hit Nearly $2 Billion Despite Rising Costs

October 30, 2025
Good news! These ‘positive tipping points’ will help save the world
Environment

Good news! These ‘positive tipping points’ will help save the world

October 30, 2025
For cardiac health, exercise benefits women more than men
Health and Wellness

For cardiac health, exercise benefits women more than men

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?